Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

132.68 +4.12 (+3.20%)
Streaming Delayed Price Updated: 1:59 PM EDT, May 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,155,082
Open 128.85
Bid (Size) 132.66 (6)
Ask (Size) 132.69 (2)
Prev. Close 128.56
Today's Range 128.85 - 132.88
52wk Range 99.71 - 141.23
Shares Outstanding 1,750,942,289
Dividend Yield 1.78%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's going on in today's session: S&P500 movers
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session. 
Via Chartmill
$34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thiner, Less Problematic Than Warfrain: Cadrenal Therapeutics, Inc. (Nasdaq: CVKD)
Via Get News
Topics Death Economy
Exposures Death Product Safety Supply Chain

Performance

YTD
+17.0%
+17.0%
1 Month
+3.7%
+3.7%
3 Month
+1.7%
+1.7%
6 Month
+14.6%
+14.6%
1 Year
+27.6%
+27.6%

More News

Read More
Recent Filing Shows That Rep. Bruce Westerman Sold Over $137K Worth of Apple Stock
Via Benzinga
ABBOTT LABORATORIES (NYSE:ABT) - A Strong Technical Setup for Breakout Investors
Via Chartmill
Reflecting On Medical Devices & Supplies - Diversified Stocks’ Q1 Earnings: Abbott Laboratories (NYSE:ABT)
Via StockStory
1 Mega-Cap Stock Worth Your Attention and 2 to Keep Off Your Radar
Via StockStory
Jensen Huang, Magic Johnson, Patrick Dempsey, Linda Yaccarino And More Bigwigs Headline Milken Global Conference 2025: What You Need To Know
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Here Are All the Dividend Kings Beating the S&P 500 in 2025 -- and the 2 That Are the Best Stocks to Buy Now
Via The Motley Fool
Topics Government Stocks World Trade
Exposures Political Tariff US Equities
2 Stocks, 2 Decades, $200. Is This the Long-Term Dividend Play for Your Portfolio?
Via The Motley Fool
If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again?
Via Investor's Business Daily
Topics Animal Testing Economy Government
Exposures Animal Testing Economy Political
Abbott Laboratories (NYSE:ABT) Shows Strong Technical Breakout Potential
Via Chartmill
A Look Into Abbott Laboratories Inc's Price Over Earnings
Via Benzinga
3 Dividend Stocks to Buy and Hold for the Next Decade
Via The Motley Fool
Exposures COVID-19
If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy
Via MarketBeat
What To Expect From Penumbra’s (PEN) Q1 Earnings
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
What To Expect From Boston Scientific’s (BSX) Q1 Earnings
Via StockStory
Topics Economy
Exposures Interest Rates
Earnings To Watch: Intuitive Surgical (ISRG) Reports Q1 Results Tomorrow
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Dividend Stock Analysis: Abbott Laboratories
Via Talk Markets
Topics Stocks / Equities
These Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected Earnings
Via Benzinga
Demystifying Abbott Laboratories: Insights From 11 Analyst Reviews
Via Benzinga
5 Dividend Aristocrats® So Good You'll Never Want to Sell
Via The Motley Fool
Tariff-Resistant Abbott Laboratories on Track for New Highs
Via MarketBeat
Topics World Trade
Exposures COVID-19 Tariff
US Stocks Likely To Open Higher Ahead Of Festive Weekend: 'Current Equity Levels Offer An Attractive Entry Opportunity'
Via Benzinga

Frequently Asked Questions

Is Abbott Laboratories publicly traded?
Yes, Abbott Laboratories is publicly traded.
What exchange does Abbott Laboratories trade on?
Abbott Laboratories trades on the New York Stock Exchange
What is the ticker symbol for Abbott Laboratories?
The ticker symbol for Abbott Laboratories is ABT on the New York Stock Exchange
What is the current price of Abbott Laboratories?
The current price of Abbott Laboratories is 132.68
When was Abbott Laboratories last traded?
The last trade of Abbott Laboratories was at 05/15/25 01:59 PM ET
What is the market capitalization of Abbott Laboratories?
The market capitalization of Abbott Laboratories is 232.31B
How many shares of Abbott Laboratories are outstanding?
Abbott Laboratories has 232B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.